Pharma-Biotech Dominates New England's $19.6 Billion of Projects Under Construction
Pharma-Biotech Dominates New England's $19.6 Billion of Projects Under Construction
Attachment: New England Projects
July 6, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--The New England market region, which includes Connecticut, Massachusetts, Maine, New Hampshire, Rhode Island and Vermont, has long been a hotspot for the Pharmaceutical-Biotech Industry and continues to hold this status. Of the more than $19.6 billion in industrial projects under construction in the region, Pharma-Biotech accounts for more than $10.4 billion worth. This is followed by the Industrial Manufacturing and Power industries.
Companies featured: Bristol-Meyers Squibb Company (NYSE:BMY), General Dynamics Corporation (NYSE:GD), Jacobs Engineering Incorporated (NYSE:J), Entergy Corporation (NYSE:ETR)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- New England Sees $27 Billion in Projects Under Construction
- Double Vision: Jacobs Ready to Spin Off Government Services
- Jacobs Solutions Has Hand in $75 Billion Worth of U.S. Projects
- New England Sees $23.3 Billion in Projects Under Construction
- Suffolk Construction at Work on $3.2 Billion in U.S. Projects